Trial Profile
A study to compare the effect of two blinded doses of Casodex [bicalutamide] (ICI 176,334 100 mg and 150mg daily) and castration [orchiectomy] in the treatment of advanced carcinoma of the prostate
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 26 Nov 2005
Price :
$35
*
At a glance
- Drugs Bicalutamide (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 26 Nov 2005 New trial record.